Literature DB >> 17186024

Nuclear PTEN: a tale of many tails.

A Gil1, A Andrés-Pons, R Pulido.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17186024     DOI： 10.1038/sj.cdd.4402073

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN： 1350-9047            Impact factor:   15.828


× No keyword cloud information.
  24 in total

1.  Nuclear PTEN deficiency causes microcephaly with decreased neuronal soma size and increased seizure susceptibility.

Authors:  Atsushi Igarashi; Kie Itoh; Tatsuya Yamada; Yoshihiro Adachi; Takashi Kato; Daisuke Murata; Hiromi Sesaki; Miho Iijima
Journal:  J Biol Chem       Date:  2018-05-07       Impact factor: 5.157

2.  A pathogenic role for germline PTEN variants which accumulate into the nucleus.

Authors:  Janire Mingo; Isabel Rodríguez-Escudero; Sandra Luna; Teresa Fernández-Acero; Laura Amo; Amy R Jonasson; Roberto T Zori; José I López; María Molina; Víctor J Cid; Rafael Pulido
Journal:  Eur J Hum Genet       Date:  2018-04-30       Impact factor: 4.246

3.  Immunohistochemical detection of p53, PTEN, Rb, and p16 in canine osteosarcoma using tissue microarray.

Authors:  Duncan S Russell; Lauren Jaworski; William C Kisseberth
Journal:  J Vet Diagn Invest       Date:  2018-04-09       Impact factor: 1.279

4.  Structural mutation analysis of PTEN and its genotype-phenotype correlations in endometriosis and cancer.

Authors:  Iris N Smith; James M Briggs
Journal:  Proteins       Date:  2016-08-13

5.  Loss of PTEN promotes podocyte cytoskeletal rearrangement, aggravating diabetic nephropathy.

Authors:  Jamie Lin; Yuanyuan Shi; Hui Peng; Xiaojie Shen; Sandhya Thomas; Yanlin Wang; Luan D Truong; Stuart E Dryer; Zhaoyong Hu; Jing Xu
Journal:  J Pathol       Date:  2015-02-19       Impact factor: 7.996

6.  PTEN lipid phosphatase activity and proper subcellular localization are necessary and sufficient for down-regulating AKT phosphorylation in the nucleus in Cowden syndrome.

Authors:  Xin He; Motoyasu Saji; Deepa Radhakrishnan; Todd Romigh; Joanne Ngeow; Qi Yu; Yu Wang; Matthew D Ringel; Charis Eng
Journal:  J Clin Endocrinol Metab       Date:  2012-09-07       Impact factor: 5.958

7.  Engineering ePTEN, an enhanced PTEN with increased tumor suppressor activities.

Authors:  Hoai-Nghia Nguyen; Jr-Ming Yang; Yashar Afkari; Ben Ho Park; Hiromi Sesaki; Peter N Devreotes; Miho Iijima
Journal:  Proc Natl Acad Sci U S A       Date:  2014-06-16       Impact factor: 11.205

8.  Autism, asthma, inflammation, and the hygiene hypothesis.

Authors:  Kevin G Becker
Journal:  Med Hypotheses       Date:  2007-04-06       Impact factor: 1.538

9.  SLC6A20 transporter: a novel regulator of brain glycine homeostasis and NMDAR function.

Authors:  Mihyun Bae; Junyeop Daniel Roh; Youjoung Kim; Seong Soon Kim; Hye Min Han; Esther Yang; Hyojin Kang; Suho Lee; Jin Yong Kim; Ryeonghwa Kang; Hwajin Jung; Taesun Yoo; Hyosang Kim; Doyoun Kim; Heejeong Oh; Sungwook Han; Dayeon Kim; Jinju Han; Yong Chul Bae; Hyun Kim; Sunjoo Ahn; Andrew M Chan; Daeyoup Lee; Jin Woo Kim; Eunjoon Kim
Journal:  EMBO Mol Med       Date:  2021-01-11       Impact factor: 12.137

10.  Suppression of cellular proliferation and invasion by the concerted lipid and protein phosphatase activities of PTEN.

Authors:  L Davidson; H Maccario; N M Perera; X Yang; L Spinelli; P Tibarewal; B Glancy; A Gray; C J Weijer; C P Downes; N R Leslie
Journal:  Oncogene       Date:  2009-11-16       Impact factor: 9.867
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.